Ensysce Biosciences Inc. Insider Trading

ENSC

⊜ Compare

Last 12 months

Insiders bought 444K on the open market and sold nothing.

Net open-market

+444K

1 buy · 0 sales

Under a 10b5-1 plan

—

no sales

Insiders who bought / sold

1 / 0

executives and directors

Last open-market buy

Aug 2026

Aug 7, 2026

Get an email when ENSC's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Apr 23 – Aug 7	Bob G Gower Director	Bought 2 parts	908,614	$0.49 average	444K	11182%	Form 4

Apr 23 – Aug 7
Bob G Gower
Director · bought 908,614 at avg $0.49
444K
11182% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch ENSC, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with ENSC

CompareIntrinsic value

KYNBKyntra Bio, Inc.

$3.96-8.12%20

BOLTBolt Biotherapeutics Inc.

$6.54-0.46%25

ATAIAtaiBeckley Inc.

$0.61-1.61%40

PRPHProPhase Labs Inc.

$0.01-42.00%0

INMInMed Pharmaceuticals Inc.

$17.50+4.17%40

PCYNProcyon Corporation

$0.18+0.00%20

CPHIChina Pharma Holdings Inc.

$0.59-3.28%15

MRKRMarker Therapeutics, Inc.

$1.01+3.06%25

Spot a number that looks wrong? Check it in ENSC's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing ENSC

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.